Insulin to Account for 32% of the Indian Diabetes Medication Marketby 2018A new report expects the Indian insulin market t...
Email: apac@imarcgroup.comPhone: +91-120-415-5099IMARC Group North AmericaEmail: america@imarcgroup.comPhone: +1-631-791-1...
Upcoming SlideShare
Loading in …5
×

Insulin to Account for 32% of the Indian Diabetes Medication Market by 2018

306 views

Published on

A new report expects the Indian insulin market to grow at a CAGR of 19% during 2013-2018.

Published in: Health & Medicine
0 Comments
0 Likes
Statistics
Notes
  • Be the first to comment

  • Be the first to like this

No Downloads
Views
Total views
306
On SlideShare
0
From Embeds
0
Number of Embeds
3
Actions
Shares
0
Downloads
4
Comments
0
Likes
0
Embeds 0
No embeds

No notes for slide

Insulin to Account for 32% of the Indian Diabetes Medication Market by 2018

  1. 1. Insulin to Account for 32% of the Indian Diabetes Medication Marketby 2018A new report expects the Indian insulin market to grow at a CAGR of 19% during 2013-2018.IMARC Group, one of the world’s leading research and advisory firms, expects the total marketfor insulin in India to grow at a CAGR of 19% during 2013-2018. Findings from its latest reportentitled “Indian Diabetes Market Report: Epidemiology, Patients, Prevalence, Oral Anti-diabetics, Insulin and Diagnostics” suggests that by 2018, insulin is expected to account for32% of the entire diabetes medication market in India.According to the report, the market for both oral anti-diabetics and insulin are experiencingrobust growth. The report cites increasing sedentary lifestyles, lack of physical activity, obesity,stress and consumption of diets rich in fat, sugar and calories as the catalysts in driving theprevalence of diabetes in India. According to an analyst at IMARC Group, “India’s rapideconomic growth in the last few decades has led to a rapid urbanization in the country. Between1991 and 2011, the proportion of people living in urban India rose from 26% to 31%; a trend thatis predicted to increase at a faster pace in the coming years. Increased prosperity has broughtan increase in sedentary lifestyles and western diets. As a result, the prevalence of diabetes inthe urban regions has been much faster compared to the rural regions”.IMARC’s new report “Indian Diabetes Market Report: Epidemiology, Patients, Prevalence,Oral Anti-diabetics, Insulin and Diagnostics” provides an analytical and statistical insight intothe Indian diabetes market. The report provides both current and future trends in theprevalence, demographical breakup, diagnosis and treatment of diabetes in India. The reporthas segmented the Indian diabetes market into three segments - Oral Anti-diabetics, Insulin andDiabetes Diagnostics. For each of the aforementioned categories, the report provides historicaland future market sales, performance of key classes and the performance of top players.To buy the complete report or to get a free sample, please contact:IMARC Group Asia
  2. 2. Email: apac@imarcgroup.comPhone: +91-120-415-5099IMARC Group North AmericaEmail: america@imarcgroup.comPhone: +1-631-791-1145IMARC Group Europe, Middle East & AfricaEmail:ema@imarcgroup.comPhone: +44-702-409-7331To know more please visit: http://www.imarcgroup.com/india-diabetes/

×